Mutations in genes observed in AITL overlap for the most part with those observed in medullary tumors [22].TET2 mutations are seen in 47% ~ 83% of AITL cases, and DNMT3A alterations are seen in 26% ~ 38% of cases. This evidence concerns the gene DNMT3A and angioimmunoblastic T-cell lymphoma.